US drug giant Pfizer on Tuesday announced a deal with MPP - a UN-backed public health organization - to issue royalty-free voluntary licence to manufacture generic versions of oral antiviral Covid-19 medication Paxlovid in 95 middle and low income countries (LMIC) including India.from Industry-Economic Times
Read The Rest:economictimes...
